MNI

The latest issue of Nature Neuroscience presents a special issue focused on the state of the art of human brain imaging. 

Classified as: BIC
Category:
Published on: 15 Mar 2017

Discovery could be key to treating brain and spinal cord injury

A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.

Classified as: MNI, Neuro, Neurology, stroke, spinal cord injury, axon repair, 14-3-3, Fusicoccin-A
Published on: 8 Mar 2017

Research and clinical care complement each other at The Neuro

February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.

Classified as: genetics, Rare disases, Bernard Brais, Eric Shoubridge, ataxia
Published on: 28 Feb 2017

The BIC hosted a series of Deep Learning workshops organized by Santiago Paiva (Hoge lab) and Dr. Robert Brown (Arnold lab) on January 19th and 26th. 

Classified as: BIC
Category:
Published on: 6 Feb 2017

We are pleased to welcome Dr. Stephan Blinder as the new BIC PET physicist on staff. 
Stephan completed his PhD in Astrophysics (U de Bordeaux I, France) and later shifted his interest towards biomedical imaging research. He worked for 4 years with the MIRG group led by Dr. Anna Celler (U of British Columbia, Vancouver) on SPECT imaging, focusing on 3D and 4D image reconstruction techniques. 

Classified as: BIC
Category:
Published on: 6 Feb 2017

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Classified as: Parkinson's, Ted Fon, ALS, Brain Canada, Canada Brain Research Fund, CQDM, Fon, Edward Fon
Published on: 2 Feb 2017

Project will enhance mental health access for multicultural communities

On Jan. 18, 2017, Bell Let’s Talk announced a donation of $250,000 to McGill University’s Montreal Neurological Institute and Hospital – known as The Neuro – to fund the development of online mental health resources focused on the needs of multicultural communities.

Classified as: Bell, mental health, Bell Let's Talk, Multicultural Mental Health Resource Centre
Published on: 18 Jan 2017

An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.

Classified as: Athletics, brain injury, sport, Concussion, alain ptito, HEADS UP
Published on: 11 Jan 2017

Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.

Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.

Classified as: neuroscience, Robert Zatorre, specific musical anhedonia, fMRI, University of Barcelona
Published on: 4 Jan 2017

Drug shown to reduce new attacks/symptom progression in some patients

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Classified as: Multiple Sclerosis, Amit Bar-Or, MS, Douglas Arnold, ocrelizumab
Published on: 22 Dec 2016

Truly happy to see Ted join our core staff as Manager, Data Resources. Ted has 12+ years experience as a programmer, database administrator and technology generalist in the industry and academia. He will assist in creating a strategy and enabling the tools for short- and long-term data management over all modalities used at our Centre, all in coordination with the developments of the MNI's open-science infrastructure. 
Ted will draw from several years supporting open source, open data, and open science through policy and organizing. 

Classified as: BIC
Category:
Published on: 13 Dec 2016

Each December for over 60 years, the Reitman family has invited all members of The Neuro to a splendid luncheon that has become an enjoyable annual tradition. This gathering shows a wonderful holiday spirit of generosity and thankfulness.

Reitman family members, Joel (President of Jillcy Investments Ltd.), Jill and Dorothy were present for the 69th Reitman Holiday Luncheon on December 9th to greet staff and to help staff volunteers serve a tasty meal to some 1,200 members of The Neuro.

Classified as: Reitman Lunch
Category:
Published on: 9 Dec 2016

Study tracks patients to better understand effects and possible treatments

December 1 is World AIDS Day, a time to raise awareness about a disease that has afflicted 70 million people worldwide, 35 million of whom have died as a result.

Classified as: HIV, AIDS, Lesley Fellows, SIDA, Cognitive neuroscience, VIH, Journée mondiale du sida
Published on: 1 Dec 2016

Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells.

Classified as: genetics, epilepsy, Peter McPherson, Epileptic encephalopathy, Chanshuai Han, DENND5A
Published on: 28 Nov 2016

Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.

Classified as: genetics, stem cells, ARSACS, Charlevoix-Saguenay, University of Saskatchewan, ARSACS Foundation, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Neuro Giving
Published on: 24 Nov 2016

Pages